Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest Diagnostics.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

The FDA is attempting to rehire some of the 300 employees it recently dismissed, including scientists responsible for ...

Philips (NYSE: PHG) issued an urgent field safety notice to warn of a potential safety issue with its IntelliSpace Cardiovascular system.

Neurovalens said its Modius Sleep insomnia treatment will be available to veterans through a U.S. Department of Veterans Affairs program.

Boston Scientific (NYSE: BSX) announced that its Europe-based subsidiary priced a public offering totaling $1.57 billion ...

(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.

The FDA today issued a notice labeling the recall of Boston Scientific Accolade pacemaker devices serious as it may cause ...

Philips today announced a collaboration with Mass General Brigham to develop and deploy data infrastructure and AI.

Globus Medical (NYSE:GMED) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.

Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...

UroMems says that the entire treatment cohort in tae first-of-its-kind study in female patients successfully reached its primary endpoints.